EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches

Guneswar Sethi, Avinash Kant Lakra, Kirti Nirmal, Jeong Ho Hwang iD

PLOS One · 18.11.2025 · 20 (11) · e0334754

DOI: 10.1371/journal.pone.0334754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.11.2025. Verfasst von Guneswar Sethi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Large Animals Convergence Research, Korea Institute of Toxicology, Jeongeup-si, Jeollabuk-do, Korea. Hauptthemen laut MEDLINE: Cryptosporidium parvum, Protozoan Vaccines, Epitopes, Cryptosporidiosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Science & Technology, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryptosporidium parvum is a waterborne protozoan parasite responsible for diarrheal illness in humans and animals. The lack of effective vaccines and the emergence of antimicrobial resistance underscore the urgent need for novel prophylactic strategies.

Methods

A structure-based immunoinformatics approach was used to design a multi-epitope subunit vaccine (MESV) targeting immunogenic regions of C. parvum . Three proteins, Cp15, Cp23, and CpP2, were selected based on antigenicity, non-allergenicity, non-homology with host proteins, and absence of transmembrane domains. B-cell, CD4 + , CD8 + , and IFN-γ-inducing epitopes were identified and screened for high antigenicity, non-allergenicity, and non-toxicity. To enhance immune recognition, the lipoprotein LprA, a TLR2 agonist, was fused at the N-terminus using an EAAAK linker, and a PADRE sequence was added to improve helper T-cell responses. Linkers were applied to ensure proper epitope separation and processing. Population coverage was analyzed to evaluate the distribution of HLA-restricted epitopes across global populations. Structural modeling and flexibility analysis (CABS-flex) were performed to assess construct stability. Interactions with TLR2 and TLR4 were examined via molecular docking and 100-ns molecular dynamics (MD) simulations, with MM-GBSA used to estimate binding free energies. Immune simulations predicted host immune responses, while codon optimization, in silico cloning, and mRNA secondary structure prediction assessed expression and transcript stability.

Results

The MESV showed strong binding to TLR2 (−1328.4 kcal/mol) and TLR4 (−1133.3 kcal/mol), with MD simulations confirming stable complexes. Immune simulations indicated robust antibody production, T-cell activation, cytokine release, and dendritic cell recruitment. The vaccine demonstrated global HLA population coverage of 95.92%, with favorable expression and mRNA folding profiles.

Conclusion

The MESV construct demonstrated strong immunogenicity, structural stability, and broad population coverage, underscoring its potential as a promising vaccine candidate against C. parvum . Furthermore, experimental validation is warranted to confirm its safety and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryptosporidium parvumProtozoan VaccinesEpitopesCryptosporidiosisHumansComputational BiologyComputer SimulationToll-Like Receptor 2Epitopes, T-LymphocyteVaccines, SubunitProtozoan ProteinsToll-Like Receptor 4Epitopes, B-LymphocyteMolecular Docking SimulationImmunoinformatics

Substanzen

Protozoan VaccinesEpitopesToll-Like Receptor 2Epitopes, T-LymphocyteVaccines, SubunitProtozoan ProteinsToll-Like Receptor 4Epitopes, B-Lymphocyte

Autor:innen und Institutionen

  • Center for Large Animals Convergence Research, Korea Institute of Toxicology, Jeongeup-si, Jeollabuk-do, Korea.
  • Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Department of Microbiology, University College of Medical Sciences, Delhi, India.
  • Division of Advanced Predictive Research, Center for Bio-Signal Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.

ORCID-Profile: Jeong Ho Hwang

Förderung

  • National Research Council of Science & Technology
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Sethi, G., Lakra, A. K., Nirmal, K., & Hwang, J. H. (2025). In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches. PLOS One, 20(11), e0334754. https://doi.org/10.1371/journal.pone.0334754

Vancouver

Sethi G, Lakra AK, Nirmal K, Hwang JH. In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches. PLOS One. 2025;20(11):e0334754. doi:10.1371/journal.pone.0334754

BibTeX
@article{Sethi2025,
  author = {Sethi, Guneswar and Lakra, Avinash Kant and Nirmal, Kirti and Hwang, Jeong Ho},
  title = {In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {11},
  pages = {e0334754},
  doi = {10.1371/journal.pone.0334754}
}
Kostenlos starten →